Whitefort Capital Management’s Roivant Sciences ROIV Stock Holding History

Whitefort Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$36.1M	Sell	1,019,000 -400,000	-28%	-$11.8M	8.89%	2
2026 Q1	$39.3M	Sell	1,419,000 -701,000	-33%	-$18M	11.59%	2
2025 Q4	$46M	Sell	2,120,000 -1,412,000	-40%	-$27.9M	11.76%	2
2025 Q3	$53.4M	Sell	3,532,000 -350,000	-9%	-$4.33M	15.79%	2
2025 Q2	$43.8M	Buy	3,882,000 +471,000	+14%	+$5.11M	16.4%	2
2025 Q1	$34.4M	Buy	3,411,000 +1,020,000	+43%	+$11M	16.19%	2
2024 Q4	$28.3M	Hold	2,391,000	–	–	13.54%	2
2024 Q3	$27.6M	Hold	2,391,000	–	–	12.56%	3
2024 Q2	$25.3M	Hold	2,391,000	–	–	15.58%	2
2024 Q1	$25.2M	Buy	2,391,000 +800,000	+50%	+$8.63M	15.35%	3
2023 Q4	$17.9M	Buy	+1,591,000	New	+$15.5M	11.39%	3
2023 Q2	–	Sell	-833,471	Closed	-$6.15M	–	16
2023 Q1	$6.15M	Sell	833,471 -575,000	-41%	-$4.73M	5.72%	5
2022 Q4	$11.3M	Buy	+1,408,471	New	+$7.83M	8.74%	4

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Whitefort Capital Management's ROIV Position: Q2 2026 in Review

Whitefort Capital Management reduced its Roivant Sciences (ROIV) stake by 28% in Q2 2026, selling an estimated $11.8M and leaving 1,019,000 shares worth $36.1M. The position accounts for 8.89% of the portfolio, ranked #2.

Whitefort Capital Management first reported a position in ROIV in Q4 2022 and has held it in 13 quarters since. The position peaked at $53.4M in Q3 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Whitefort Capital Management held 1,019,000 shares of Roivant Sciences worth $36.1M as of Q2 2026.
Whitefort Capital Management sold 400,000 Roivant Sciences shares in Q2 2026, an estimated $11.8M.
Roivant Sciences made up 8.89% of Whitefort Capital Management's portfolio in Q2 2026, its #2 holding.
Whitefort Capital Management first reported a position in Roivant Sciences in Q4 2022 and has held it in 13 quarters since.
Whitefort Capital Management's Roivant Sciences position peaked at $53.4M in Q3 2025.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Whitefort Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.